ArticleFrontiers in neurology
TrkB activation mitigates blast-induced cochlear pathology and promotes auditory recovery in a compressed-air blast model.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Blast-induced hearing loss (BIHL) is a prevalent form of sensory neurotrauma resulting from military and occupational blast exposure. However, effective post-injury interventions remain limited, and progress is hindered by challenges in delivering therapeutics to the injured cochlea. In this study, we developed a reproducible compressed-air blast mouse model with quantified output characteristics and evaluated a localized post-blast TrkB activation strategy using 7,8-dihydroxyflavone (7,8-DHF) delivered to the cochlea via poly(lactide-co-glycolide)-graft-polyethylenimine (PgP) nanoparticles. Device characterization demonstrated a monotonic relationship between regulator-setting pressure (100-250 psi) and acoustic output (72-124 dB). In addition, device modification increased acoustic output while reducing peak pressure relative to the prior configuration, thereby enabling reproducible, pressure-dependent injury. A single unilateral blast exposure produced robust elevations in auditory brainstem response (ABR) thresholds that partially recovered at intermediate regulator settings; however, these thresholds remained elevated over time at higher regulator settings. Since the modified blast paradigm frequently produced tympanic membrane perforation, we leveraged this transient access route to deliver 7,8-DHF-loaded nanoparticles through the ear canal immediately after blast. Compared with vehicle treatment, local 7,8-DHF delivery accelerated functional recovery and yielded significantly improved ABR thresholds, whereas vehicle-treated mice remained persistently impaired at 1 month. Histological analyses revealed preserved inner hair cell density, but significant outer hair cell loss and reduced inner hair cell ribbon synapses in mice exposed to blast. 7,8-DHF-loaded PgP attenuated outer hair cell loss and partially preserved ribbon synapses, with the strongest protection in basal cochlear regions. Together, these findings provide an accessible BIHL platform and support nanoparticle-enabled local TrkB activation as a feasible post-blast strategy that improves both functional and structural endpoints relevant to sensory neurotrauma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.